Importantly, although FAP has been implicated in regression of epithelial tumors mediated by Val-boroPro and other boronated dipeptides targeting extracellular enzymes, our data suggest that inhibition of intracellular DPPs may also contribute to tumor regression. The gene discussed is FAP; the disease is neoplasm.